Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Pfizer vaccine inequality

A Bangladeshi health worker administers a dose of the Pfizer-BioNTech coronavirus vaccine in the capital Dhaka on November 1, 2021. (Photo: Piyas Biswas/SOPA Images/LightRocket via Getty Images)

Pfizer Misleading World With False Claims of Equitable Vaccine Distribution: Amnesty

"As much as these companies might want to massage the facts, the numbers are crystal clear—they are still supplying the majority of their doses to richer parts of the world."

Brett Wilkins

A briefing published Thursday by Amnesty International accused pharma giant Pfizer of making misleading claims about its efforts to provide Covid-19 vaccines to low-income countries, while reserving most doses of the inoculations for wealthier nations.

"Pfizer says it is committed to supplying doses to low- and middle-income countries, but the numbers just don't bear this out. The fact is that this company is still putting profits first."

"Two years after the emergence of the deadly coronavirus, half the world's population [has] received at least one dose of the vaccine—a major milestone on the path to global vaccination," the human rights group says. "Yet a staggering 96% of people in low-income countries remain unvaccinated."

"Despite the ever-increasing numbers of vaccines produced, both states and pharmaceutical companies are continuing to fail to guarantee fair access to lifesaving medicines for all," the briefing contends.

"Pfizer, one the largest and most profitable vaccine developers... has delivered in excess of 1.8 billion doses to date," the publication continues. "Despite its many pledges—some misleadingly phrased—Pfizer... continues to reserve the bulk of its vaccines for higher-income countries."

The report notes that the company is "still refusing to participate in technology sharing initiatives, such as the South African-based [World Health Organization] mRNA technology hub, and has lobbied vigorously against efforts to lift intellectual property restrictions."

"With projected earnings of U.S.$36 billion from vaccines for 2021, Pfizer is still putting profits before people," Amnesty charges.

According to the briefing, Pfizer's claims that its coronavirus vaccine "would be available to every patient, country, and community that seeks access," and that the company's priority was "fair and equitable distribution" of doses, are misleading.

In a June 2021 letter to Amnesty, Pfizer pledged "to provide two billion doses of our Covid-19 vaccine to middle- and low-income countries over the next 18 months," and to deliver 40% of its planned vaccine supply to such nations.

"This claim gives the impression that lower-income countries are receiving a substantial proportion of Pfizer vaccines, but the language is misleading," the briefing asserts. "Pfizer has amalgamated low, lower-middle, and upper-middle countries—over 84% of the global population—into one group and referred to them as 'low and middle-income.' Within this very broad category, the bulk of Pfizer's doses have in fact been going to 'upper-middle' income countries such as Malaysia, Mexico, and Thailand."

Additionally, while Pfizer said it had shipped two billion vaccine doses by the end of September, the company admitted to Amnesty in November that only 154 million doses, or less than 8% of its total—had been sent to 42 low and lower-middle-income countries, and that less than 10% of those shots had gone to low-income countries.

Furthermore, while Pfizer claimed it is "committed to sharing our scientific tools and insights, development expertise, and manufacturing capacity," the briefing notes the company "has opposed sharing of intellectual property through the WHO's Covid-19 Technology Access Pool (C-TAP) and has not joined the newly established Covid-19 mRNA vaccine technology transfer hub in South Africa."

Amnesty also notes that Pfizer has lobbied the Biden administration "to oppose proposals put forward by India and South Africa to the World Trade Organization Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) to suspend critical intellectual property provisions of the TRIPS Agreement, which it describes as a disincentive to investment and innovation."

Patrick Wilcken, Amnesty's head of business and human rights, said in a statement Thursday that "Pfizer says it is committed to supplying doses to low- and middle-income countries, but the numbers just don't bear this out. The fact is that this company is still putting profits first."

"As much as these companies might want to massage the facts, the numbers are crystal clear—they are still supplying the majority of their doses to richer parts of the world," he continued.

"We're still in the middle of an unprecedented global health and human rights crisis," Wilcken added, "and it is essential that all countries of the world have access to vaccines as soon as possible."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

UN Officials Warn of 'Record-Shattering Month' for Civilian Deaths in Yemen

Following deadly strikes by the Saudi-led coalition, Oxfam is calling on the U.N. Security Council to condemn attacks on Yemenis and to "inject new urgency" into peace talks.

Jessica Corbett ·


Experts Say Nuclear Energy as Climate Solution Is Total 'Fiction'

"The reality is nuclear is neither clean, safe, or smart; but a very complex technology with the potential to cause significant harm."

Jessica Corbett ·


Air and Water Under Threat as SCOTUS Targets Environmental Laws

"It seems like we have a new conservative supermajority on the court that is much more inclined to do a slash-and-burn expedition through our major environmental laws."

Julia Conley ·


'Historic Turning Point': Cuba Issues Plan for Vaccine Internationalism

"This lifesaving package," said the head of Progressive International's delegation to Cuba, exemplifies public health and science being "placed above private profit and petty nationalism."

Kenny Stancil ·


Fridays For Future Announces Global Climate Strike for March 25

"Join us for the Global Climate Strike as we demand policymakers and world leaders to prioritize #PeopleNotProfit!"

Common Dreams staff ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo